CAELYX PEGYLATED LIPOSOMAL 2 mg/ml, concentrate for solution for infusion bottle, 10 ml
Active ingredients: Doxorubicin hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Concentrate for solution for infusionbottle, 10 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CAELYX PEGYLATED LIPOSOMAL 2 mg/ml, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre de 10 ml
- Marketing authorisation holder
- BAXTER HOLDING (PAYS-BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Mar 1998
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by a hospital doctor
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62362369CIP75603619CIP133400956036196Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE DOXORUBICINEsolution | 2 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.